Columbia Care: Analysts Expect $17.2 Million In Q2 EBITDA
Columbia Care Inc. (CSE: CCHW) announced that they will be reporting their second quarter financials before the market opens on August 12.
Analysts have a consensus C$313.77 12-month price target on the company, via a total of 12 analysts, with 5 analyst having a strong buy rating, 6 analysts have a buy rating and a single analyst has a hold rating. The street high comes in at a C$19 price target, and the lowest target comes in at a C$5.75 price target.
7 analysts have revenue estimates for the second quarter. The mean between all 7 is C$$108.39 million; this number has been revised slightly higher from $106.96 million at the start of the year. The street high is C$129.60 million while the lowest sits at $100.67 million.
Four analysts have estimates for what this quarter’s gross profit margin will be. They expect the profit margin to come in at 45.35%, with this number being revised slightly higher from 44% at the start of the year. Street high goes to Needham & Co with a 46% estimate and the lowest sits at 45%.
Onto EBITDA estimates, there are currently 7 analysts who have second quarter EBITDA estimates. The mean is currently $17.15 million, with this number being slightly lower than at the start of the year. Street high goes to Ladenburg Thalmann with a $20.55 million EBITDA estimate, and the lowest being a $14.20 million estimate.
Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.
